T1	Participants 214 285	patients with exacerbated bronchial asthma who required hospitalization
T2	Participants 312 361	known asthmatics admitted with acute exacerbation
T3	Participants 401 427	Two groups were randomized
T4	Participants 429 490	Group I for Albuterol powder 200 micrograms inhaled q 4 hours
T5	Participants 492 557	Group II with Albuterol nebulized solution 2.5 mg inhaled q 4 hrs
T6	Participants 905 984	Fifteen patients enrolled in both groups, two patients of group I were excluded
T7	Participants 1058 1177	Both groups were comparable with respect to sex, asthma exacerbations/year, smoking history and hospital length of stay
